Skip to main content

This translation is provided for general access and has no recorded medical-language review.

Editorial general information — not a clinical-review record

Published: Updated: Publisher: Dr. Murat Toktamışoğlu

How should lower-face and smile asymmetry after botulinum toxin be documented?

Lower-face botulinum toxin can alter balance among small muscles; a difference absent at rest may appear with smiling, speech, lip pursing or fluid control. Pre-existing asymmetry and new functional loss need a comparative video and timeline.

This translation has no recorded clinical or medical-language review.

Direct answer

  • A resting photograph cannot show dynamic lip function.
  • New speech, swallowing or fluid-leak symptoms are more than an aesthetic asymmetry.
  • Early balancing toxin on the opposite side can create another functional deficit.

The value of a baseline video

Before treatment, record short standardized clips at rest, gentle and full smile, speech, lip purse, lower-tooth show and chin movement. Note dental and jaw factors, prior facial palsy and congenital muscle differences. A later comparison can use actual function rather than memory of the former appearance.

Regional muscle balance

Mouth-corner, lower-lip and chin movement depends on nearby small muscles working together. Spread to an adjacent muscle or baseline strength differences may change appearance. Record product, concentration, regional units, points and date. Greater movement on one side does not automatically justify injecting that side.

Function comes first

Speech change, inability to retain liquids, marked chewing or swallowing difficulty and generalized weakness need separate medical assessment. A mild aesthetic difference may evolve as effect changes, while rushed balancing can increase risk. Review video, symptoms and function together. Replan only after resolution, without promising perfect symmetry.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

  1. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information

    U.S. Food and Drug Administration (FDA) · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  2. Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis of Clinical Studies

    Alaa Safia, Uday Abd Elhadi, Shlomo Merchavy, Ramzy Batheesh, Naji Bathish · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  3. Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis

    David Zargaran, Florence Zoller, Alexander Zargaran, Eqram Rahman, Alexander Woollard, Tim Weyrich, Afshin Mosahebi · 2022

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  4. The Treatment of Facial Asymmetry with Botulinum Toxin: Current Concepts and Guidelines

    I. Heydenrych · 2020

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  5. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis

    Systematic review authors · 2016

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review